Smith, Sydney E. http://orcid.org/0000-0002-5293-7247
Kosik, Eena L.
van Engen, Quirine
Kohn, Jordan
Hill, Aron T. http://orcid.org/0000-0002-1435-2993
Zomorrodi, Reza
Blumberger, Daniel M. http://orcid.org/0000-0002-8422-5818
Daskalakis, Zafiris J.
Hadas, Itay http://orcid.org/0000-0001-7518-1182
Voytek, Bradley http://orcid.org/0000-0003-1640-2525
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM134363)
Article History
Received: 24 August 2023
Revised: 9 October 2023
Accepted: 13 October 2023
First Online: 16 November 2023
Competing interests
: ATH was supported by an Alfred Deakin Postdoctoral Research Fellowship. DMB receives research support from the Canadian Institutes of Health Research (CIHR), National Institutes of Health – US (NIH), Brain Canada Foundation and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. and he was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He received in-kind equipment support from Magventure for investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. He has participated in an advisory board for Janssen. He has participated in an advisory board for Welcony Inc. ZJD has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc and industry-initiated trials through Magnus Inc. He also currently serves on the scientific advisory board for Brainsway Inc. His work has been supported by the National Institutes of Mental Health (NIMH), the Canadian Institutes of Health Research (CIHR), Brain Canada and the Temerty Family, Grant and Kreutzcamp Family Foundations.